Metastatic Pancreatic Endocrine Tumor Presenting as Thoracic Spinal Cord Compression

被引:7
作者
Eads, Todd Alin [1 ]
Hattab, Eyas M. [2 ]
Rodgers, Richard B. [1 ]
机构
[1] Indiana Univ Sch Med, Dept Neurol Surg, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA
关键词
metastasis; neuroendocrine tumor; spinal cord compression; spine; pancreatic tumor;
D O I
10.1097/BRS.0b013e3181cb4730
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Study Design. A case report. Objective. The authors present a rare case of metastatic nonfunctioning neuroendocrine tumor of the pancreas presenting as thoracic spinal cord compression. Summary of Background Data. Pancreatic endocrine tumors (PETs) are a slow-growing subset of pancreatic tumors. They can be classified as either functioning or nonfunctioning. To our knowledge, this is the second reported case of a PET presenting as spinal cord compression. Methods. The clinical course, radiologic features, pathology, and outcome of the metastasis of PET are reported. Results. A 59-year-old woman presenting with a 2-week history of midthoracic back pain and early signs of myelopathy. A computed tomography scan and magnetic resonance imaging revealed multiple mildly enhancing lesions within T5, T7, T8, and L1 vertebral bodies with ventral epidural and bilateral T8-T9 neuroforaminal soft tissue extension causing severe spinal canal stenosis. A computed tomography-guided biopsy was in conclusive, and we performed a T7-T9 laminectomy with T8 bilateral transpedicular decompression and T6 to T10 pedicle screw fixation and posterolateral fusion with subtotal resection of the tumor. Pathology was consistent with low-grade neuroendocrine tumor. The patient recovered well, and an octreotide scan ultimately revealed an area of abnormal uptake within the body of the pancreas. Conclusion. We have reported a rare case of a metastatic PET presenting as spinal cord compression.
引用
收藏
页码:E510 / E513
页数:4
相关论文
共 15 条
[1]  
Bailey D, 2001, Conn Med, V65, P585
[2]   Nonfunctioning islet cell tumors of the pancreas: Clinical, imaging and pathological aspects in 16 patients [J].
Furukawa, H ;
Mukai, K ;
Kosuge, T ;
Kanai, Y ;
Shimada, K ;
Yamamato, J ;
Mizuguchi, Y ;
Ushio, K .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1998, 28 (04) :255-261
[3]   Bone metastases in patients with gastrinomas: A prospective study of bone scanning, somatostatin receptor scanning, and magnetic resonance image in their defection, frequency, location, and effect of their detection on management [J].
Gibril, F ;
Doppman, JL ;
Reynolds, JC ;
Chen, CC ;
Sutliff, VE ;
Yu, F ;
Serrano, J ;
Venzon, DJ ;
Jensen, RT .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (03) :1040-1053
[4]   Insulinoma [J].
Grant, CS .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2005, 19 (05) :783-798
[5]  
HANLY EJ, 2006, NEOPLASMS ENDOCRINE
[6]  
JANI N, 2004, VISIBLE HUMAN J ENDO, P3
[7]  
Jensen Robert T., 1993, P931
[8]  
JENSEN RT, 1998, SLEISENGER FORDTRANS, P871
[9]   Experiences with nonfunctioning neuroendocrine neoplasms of the pancreas [J].
Kang, CM ;
Kim, KS ;
Choi, JS ;
Lee, WJ ;
Kim, BR .
DIGESTIVE SURGERY, 2005, 22 (06) :453-458
[10]  
KIRKPATRICK D B, 1975, Surgical Neurology, V4, P283